CIK 0001831915 · Accelerated filer
Cytek Biosciences, Inc.
Sign in to watch- Ticker
- CTKB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472547526
- Phone
- (877) 922-9835
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 15,706 shares (option exercise)
- 4 Option exercise Director acquired 15,706 shares (option exercise)
- 4 Option exercise Director acquired 15,706 shares (option exercise)
- 4 Option exercise Director acquired 15,706 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 35,000 shares at $2.78 ($97,300)
- SD Other Specialized Disclosure
- 4 Shares withheld for taxes Chief Financial Officer gave up 13,237 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 11,855 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER gave up 6,575 shares (to pay taxes)
Page 5 of 24 · 464 filings